Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26
MDxHealth (NASDAQ: MDXH) will release fourth quarter and full year 2025 financial results after market close on February 26, 2026.
Rhea-AI Summary
MDxHealth (NASDAQ: MDXH) will release fourth quarter and full year 2025 financial results after market close on February 26, 2026. A conference call and live webcast with Q&A is scheduled for February 26, 2026 at 4:30pm ET / 22:30 CET.
Investors can join via listed dial‑in numbers or the provided webcast link and should connect 15 minutes early; a replay will be available on the company website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – MDXH
On Feb 13, the first trading day after this news, MDXH closed 0.58% below the previous close.
Data tracked by StockTitan Argus for the Feb 13 session.
Key Figures
- Earnings release date
- February 26, 2026
- Q4 and full-year 2025 financial results release
- Conference call time (ET)
- 4:30pm ET
- Earnings conference call start time
- Conference call time (CET)
- 22:30 CET
- Earnings conference call start time
- Conference ID
- 10206764
- Identifier for dialing into earnings call
- US dial-in
- 1-844-825-9789
- United States conference call access number
- International dial-in
- 1-412-317-5180
- International conference call access number
- Belgium dial-in
- 0800 38 961
- Belgium conference call access number
- UK dial-in
- 0800 279 9489
- United Kingdom conference call access number
Previous Earnings Reports
-
Reported Q3 2025 growth and Exosome Diagnostics acquisition but shares fell sharply.
-
Strong Q4 and 2024 growth with improved losses and maintained 2025 guidance.
-
Q3 2024 revenue growth and guidance raise alongside equity offering and higher losses.
-
Fourth quarter and full-year 2023 financial results release with a negative price reaction.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26
Company to Host Conference Call with Live Q&A, February 26, 2026, at 4:30pm ET / 22:30 CET
IRVINE, California – February 12, 2026 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will release its financial results for the fourth quarter and full year ended December 31, 2025, after market close on Thursday, February 26, 2026.
| Title: | Mdxhealth Presents Fourth Quarter and Full Year 2025 Financial Results and Corporate Update Conference Call and Webcast |
| Date: | February 26, 2026 |
| Time: | 4:30pm ET/ 22:30 CET |
| Conference Call Dial-in Details: | United States: 1-844-825-9789 Int’l: 1-412-317-5180 Belgium: 0800 38 961 United Kingdom: 0800 279 9489 |
| Conference ID: | 10206764 |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1753070&tp_key=27bce7d4de |
The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company’s website.
About Mdxhealth
Mdxhealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests are based on proprietary genomic, epigenetic (methylation), exosomal and other molecular technologies and assist physicians with the diagnosis and prognosis of urologic cancers and other urologic diseases. The Company’s U.S. headquarters and laboratory operations are in Irvine, California, with additional laboratory operations in Waltham, Massachusetts and Plano, Texas. European headquarters are in Herstal, Belgium. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.
For more information:
info@mdxhealth.com
LifeSci Advisors (IR & PR)
John Fraunces
Managing Director
Tel: +1 917 355 2395
Jfraunces@lifesciadvisors.com
Attachment
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.